Literature DB >> 16682095

Regulated readthrough: a new method for the alternative tagging and targeting of recombinant proteins.

Thomas Bouquin1, Poul Baad Rasmussen, Per-Anders Bertilsson, Jens Sigurd Okkels.   

Abstract

We report here a new method for the alternative peptide tagging of recombinant proteins from mammalian cell lines. This method, which we called regulated readthrough, exploits the property of aminoglycoside antibiotics to promote translational readthrough of nonsense codons. The basic expression cassette includes a translational fusion between a gene of interest and a membrane targeting peptide, which are separated by a nonsense codon. In the presence of an aminoglycoside antibiotic, translational readthrough is promoted and results in the targeting of the fusion protein to the cell membrane, thus allowing the efficient flow cytometry-based isolation of cells expressing very high levels of recombinant protein. For downstream applications requiring the production of soluble recombinant protein, the cells are cultured in the absence of aminoglycoside, leading to an efficient translational termination. By combining different translation termination signals that exhibit various susceptibilities to aminoglycoside-mediated translational readthrough with flow cytometry capabilities, it is possible to use this technology for other applications such as functional library screening or monitoring the stability of recombinant protein production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682095     DOI: 10.1016/j.jbiotec.2006.03.028

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  2 in total

1.  Amber suppression coupled with inducible surface display identifies cells with high recombinant protein productivity.

Authors:  Lina Chakrabarti; Li Zhuang; Gargi Roy; Michael A Bowen; William F Dall'Acqua; Pam Hawley-Nelson; Marcello Marelli
Journal:  Biotechnol Bioeng       Date:  2019-01-18       Impact factor: 4.530

2.  SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell level.

Authors:  Christel Aebischer-Gumy; Pierre Moretti; Romain Ollier; Christelle Ries Fecourt; François Rousseau; Martin Bertschinger
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.